Bile acids regulate lipid metabolism through selective actions on fatty acid absorption.
Chan AP, Jarrett KE, Lai RW, Brearley-Sholto MC, Cheng AS, Taveras MO, Iwata AM, Steel ME, Lau A, Whang EC, Kennelly JP, Gao Y, Rubert GE, Schmidt HM, Smith EP, Su B, Williams KJ, Tarling EJ, de Aguiar Vallim TQ
Key Finding
Researchers discovered that reducing bile acids in mice prevented diet-induced obesity while selectively blocking absorption of saturated fats but preserving healthy polyunsaturated fats.
What This Study Found
Statistics Decoded
Why This Matters
This discovery could revolutionize obesity treatment by targeting the body's natural fat absorption system rather than broadly blocking all fats - potentially allowing people to absorb healthy fats while blocking unhealthy ones. Unlike current approaches that cause unpleasant side effects from blocking all fat absorption, this bile acid pathway offers a more sophisticated, selective intervention.
Original Abstract
Intestinal lipid absorption, the entry point for fats into the body, requires the coordinated actions of bile acids and lipases. Here, we uncover distinct yet cooperative roles of bile acids in driving the differential uptake of dietary fatty acids. We first decreased the bile acid pool size by disrupting the rate-limiting enzyme in bile acid synthesis, Cyp7a1, using liver-directed gene editing in mice. Compared with lipase inhibition, reduced bile acids prevented diet-induced obesity, increased anorectic hormones, suppressed excessive eating, and improved systemic lipid metabolism. Remarkably, decreasing bile acids selectively reduced the absorption of saturated fatty acids but preserved polyunsaturated fatty acids. By targeting additional bile acid enzymes, we identified specific functions of individual bile acid species. Mechanistically, we show that cholic acid preferentially solubilizes polyunsaturated fatty acids into mixed micelles for intestinal uptake. Our studies demonstrate that bile acids can selectively control fatty acid uptake, revealing insights for future interventions in metabolic diseases.